Shopping Cart 0
Cart Subtotal
USD 0

PhaseBio Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

PhaseBio Pharmaceuticals Inc (PhaseBio) is a clinical-stage biopharmaceutical company that develops biotherapeutics for the treatment of orphan diseases and cardiopulmonary indications. The company offers ELP biopolymer technology, which includes PE0139 and PB1023 pipeline products. PhaseBio's products PE0139, is a long-acting basal insulin for the treatment of hyperglycemia associated with diabetes dosed as a once-weekly injection and PB1023 is a recombinant GLP-1 analogue genetically fused to ELP biopolymer that is designed as a once-weekly treatment for hyperglycemia associated with type 2 diabetes. The company develops drugs for the treatment of endocrine, metabolic and cardiovascular disease. PhaseBio is headquartered in Malvern, Pennsylvania, the US.

PhaseBio Pharmaceuticals Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

PhaseBio Pharma Raises USD34 Million in Series D Venture Financing 11

PhaseBio Pharma Raises USD6.6 Million in Venture Financing 13

PhaseBio Pharma Raises USD40 Million in Series C Venture Financing 14

PhaseBio Pharma Raises Additional USD 23 Million In The Third Tranche Of Series B Financing Round 16

Licensing Agreements 18

PhaseBio Pharma Enters into Licensing Agreement with MedImmune 18

Duke University Enters into Licensing Agreement with PhaseBio Pharma 19

Equity Offering 20

PhaseBio Pharma to Raise up to USD70 Million in Initial Public Offering of Shares 20

Debt Offering 21

PhaseBio Pharma to Raise USD8.1 Million in Second Tranche of Private Placement of Convertible Notes 21

PhaseBio Pharma Raises USD14.7 Million in Private Placement of Convertible Notes 23

PhaseBio Pharmaceuticals Inc-Key Competitors 25

PhaseBio Pharmaceuticals Inc-Key Employees 26

PhaseBio Pharmaceuticals Inc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Corporate Communications 28

Jul 19, 2018: PhaseBio appoints Caroline M. Loewy to board of directors 28

Mar 05, 2018: PhaseBio Announces Board Changes 29

Product News 30

02/27/2018: PhaseBio Awarded USD 2.8 Million NIH SBIR Grant to Support Clinical Development of PB1046 in Pulmonary Arterial Hypertension 30

Clinical Trials 31

Nov 01, 2017: PhaseBio Announces Dosing of First Patient in an Exploratory Clinical Study of PB1046 for the Treatment of Pulmonary Arterial Hypertension 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

PhaseBio Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8

PhaseBio Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

PhaseBio Pharma Raises USD34 Million in Series D Venture Financing 11

PhaseBio Pharma Raises USD6.6 Million in Venture Financing 13

PhaseBio Pharma Raises USD40 Million in Series C Venture Financing 14

PhaseBio Pharma Raises Additional USD 23 Million In The Third Tranche Of Series B Financing Round 16

PhaseBio Pharma Enters into Licensing Agreement with MedImmune 18

Duke University Enters into Licensing Agreement with PhaseBio Pharma 19

PhaseBio Pharma to Raise up to USD70 Million in Initial Public Offering of Shares 20

PhaseBio Pharma to Raise USD8.1 Million in Second Tranche of Private Placement of Convertible Notes 21

PhaseBio Pharma Raises USD14.7 Million in Private Placement of Convertible Notes 23

PhaseBio Pharmaceuticals Inc, Key Competitors 25

PhaseBio Pharmaceuticals Inc, Key Employees 26

PhaseBio Pharmaceuticals Inc, Other Locations 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

PhaseBio Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.